Baxter EBITDA Margin 2010-2025 | BAX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Baxter (BAX) over the last 10 years. The current EBITDA margin for Baxter as of March 31, 2025 is .
| Baxter EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $10.77B | $1.41B | 13.04% |
| 2024-12-31 | $10.64B | $1.49B | 13.97% |
| 2024-09-30 | $9.54B | $1.51B | 15.82% |
| 2024-06-30 | $9.44B | $1.93B | 20.41% |
| 2024-03-31 | $9.34B | $1.64B | 17.51% |
| 2023-12-31 | $10.36B | $1.69B | 16.32% |
| 2023-09-30 | $8.97B | $0.68B | 7.54% |
| 2023-06-30 | $9.98B | $0.97B | 9.75% |
| 2023-03-31 | $9.86B | $1.28B | 13.00% |
| 2022-12-31 | $10.06B | $1.38B | 13.75% |
| 2022-09-30 | $13.79B | $1.96B | 14.24% |
| 2022-06-30 | $13.40B | $2.11B | 15.77% |
| 2022-03-31 | $12.91B | $2.15B | 16.68% |
| 2021-12-31 | $12.15B | $2.22B | 18.25% |
| 2021-09-30 | $12.45B | $2.59B | 20.81% |
| 2021-06-30 | $12.20B | $2.55B | 20.91% |
| 2021-03-31 | $11.82B | $2.46B | 20.78% |
| 2020-12-31 | $11.67B | $2.46B | 21.04% |
| 2020-09-30 | $11.53B | $2.58B | 22.39% |
| 2020-06-30 | $11.41B | $2.60B | 22.80% |
| 2020-03-31 | $11.53B | $2.63B | 22.77% |
| 2019-12-31 | $11.36B | $2.59B | 22.81% |
| 2019-09-30 | $11.14B | $2.42B | 21.70% |
| 2019-06-30 | $11.05B | $2.30B | 20.82% |
| 2019-03-31 | $11.06B | $2.31B | 20.85% |
| 2018-12-31 | $11.10B | $2.36B | 21.22% |
| 2018-09-30 | $11.08B | $2.26B | 20.40% |
| 2018-06-30 | $11.02B | $2.16B | 19.62% |
| 2018-03-31 | $10.79B | $2.12B | 19.61% |
| 2017-12-31 | $10.58B | $2.04B | 19.26% |
| 2017-09-30 | $10.43B | $2.07B | 19.80% |
| 2017-06-30 | $10.28B | $1.97B | 19.18% |
| 2017-03-31 | $10.26B | $1.72B | 16.71% |
| 2016-12-31 | $10.16B | $1.55B | 15.20% |
| 2016-09-30 | $10.12B | $1.39B | 13.68% |
| 2016-06-30 | $10.05B | $1.30B | 12.97% |
| 2016-03-31 | $9.94B | $1.31B | 13.14% |
| 2015-12-31 | $9.97B | $1.21B | 12.12% |
| 2015-09-30 | $10.15B | $1.26B | 12.36% |
| 2015-06-30 | $10.38B | $1.27B | 12.21% |
| 2015-03-31 | $12.06B | $1.90B | 15.78% |
| 2014-12-31 | $13.50B | $2.53B | 18.75% |
| 2014-09-30 | $15.03B | $2.75B | 18.28% |
| 2014-06-30 | $16.03B | $3.29B | 20.51% |
| 2014-03-31 | $15.55B | $3.39B | 21.79% |
| 2013-12-31 | $15.15B | $3.38B | 22.30% |
| 2013-09-30 | $14.33B | $3.47B | 24.23% |
| 2013-06-30 | $14.09B | $3.57B | 25.30% |
| 2013-03-31 | $14.00B | $3.51B | 25.09% |
| 2012-12-31 | $13.94B | $3.48B | 24.99% |
| 2012-09-30 | $14.03B | $3.57B | 25.47% |
| 2012-06-30 | $14.03B | $3.54B | 25.21% |
| 2012-03-31 | $14.00B | $3.58B | 25.58% |
| 2011-12-31 | $13.89B | $3.62B | 26.03% |
| 2011-09-30 | $13.80B | $3.53B | 25.56% |
| 2011-06-30 | $13.54B | $3.56B | 26.27% |
| 2011-03-31 | $13.20B | $3.43B | 25.95% |
| 2010-12-31 | $12.84B | $2.82B | 21.97% |
| 2010-09-30 | $12.82B | $3.02B | 23.60% |
| 2010-06-30 | $12.74B | $2.97B | 23.30% |
| 2010-03-31 | $12.67B | $3.00B | 23.70% |
| 2009-12-31 | $12.56B | $3.52B | 27.98% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.652B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $155.727B | 38.99 |
| Stryker (SYK) | United States | $146.049B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $127.608B | 0.00 |
| Medtronic (MDT) | Ireland | $106.425B | 15.09 |
| Haleon (HLN) | United Kingdom | $51.105B | 29.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.009B | 0.00 |
| ResMed (RMD) | United States | $35.893B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.299B | 15.34 |
| Agilent Technologies (A) | United States | $31.909B | 20.73 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Insulet (PODD) | United States | $22.874B | 89.79 |
| Koninklijke Philips (PHG) | Netherlands | $21.656B | 15.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.236B | 11.71 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.683B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.228B | 13.19 |
| Prestige Consumer Healthcare (PBH) | United States | $4.233B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.680B | 9.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.319B | 24.48 |
| Haemonetics (HAE) | United States | $3.253B | 14.82 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| GN Store Nord (GNNDY) | Denmark | $2.224B | 18.42 |
| QuidelOrtho (QDEL) | United States | $2.074B | 14.27 |
| LeMaitre Vascular (LMAT) | United States | $1.857B | 41.51 |
| AtriCure (ATRC) | United States | $1.711B | 0.00 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| Neogen (NEOG) | United States | $1.272B | 16.28 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.109B | 24.95 |
| BioLife Solutions (BLFS) | United States | $1.039B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.990B | 12.65 |
| InMode (INMD) | Israel | $0.927B | 9.34 |
| CeriBell (CBLL) | United States | $0.608B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.510B | 4.23 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.428B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 53.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.57 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.229B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Quanterix (QTRX) | United States | $0.202B | 0.00 |
| Brainsway (BWAY) | Israel | $0.193B | 51.00 |
| Biote (BTMD) | United States | $0.189B | 5.32 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 0.00 |
| Jin Medical (ZJYL) | China | $0.118B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Agape ATP (ATPC) | $0.087B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.029B | 38.86 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |